Want to see OMDA full AI Analyst Report?
OMDA Stock Chart & Stats
$23.31
-$0.13(-0.63%)
At close: 4:00 PM EDT
$23.31
-$0.13(-0.63%)
Day’s Range― - ―
52-Week Range$10.28 - $26.92
Previous Close$18.29
Volume562.89K
Average Volume (3M)1.28M
Market Cap
$1.25B
Enterprise Value$1.18B
Total Cash (Recent Filing)$221.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)300.0
Beta2.06
Next Earnings
Nov 05, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding61,216,700
10 Day Avg. Volume1,794,424
30 Day Avg. Volume1,280,499
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)4.01
Price to Sales (P/S)3.54
P/FCF Ratio54.46
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue3.82
Enterprise Value/Gross Profit5.60
Enterprise Value/Ebitda100.56
Forecast
1Y Price Target
$28.27Price Target Upside21.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)0.36
Revenue Forecast (FY)$338.67M
Bulls Say, Bears Say
Bulls Say
Rapid Revenue And Membership GrowthQ2 growth and raised guidance indicate demand is scaling across the platform, while membership expansion broadens the contracted base. A larger member footprint can support stronger customer economics and operating leverage, making the growth trajectory more durable over the next several quarters.
Margin Expansion And Operating LeverageGross-margin expansion and lower operating-expense intensity show the model is converting scale into better economics. Falling cost to serve, longer member activity and strong incremental EBITDA margin support a credible path to sustained profitability as volume grows.
Strong Cash Position And No DebtApproximately $222 million of cash and no debt give Omada financial flexibility to invest in products, channels and clinical capabilities without near-term leverage pressure. This cushion also improves resilience while the company scales its recently improved operations.
Bears Say
Profitability Remains Newly EstablishedDespite sharply improved margins, the annual financial summary still shows negative EBIT, EBITDA and net income, and says profitability has only recently improved. Until positive earnings persist across multiple periods, returns and internal funding capacity remain less proven.
GLP-1 Coverage UncertaintyEmployer decisions on GLP-1 coverage could produce uneven demand for a growing product area, with some employers expanding coverage and others withdrawing. That uncertainty may slow adoption, complicate sales planning and limit how quickly GLP-1 initiatives contribute to revenue.
Early-Stage Channel Execution RiskSeveral PBM partnerships and the first prescribing partner remain early-stage, while one PBM channel is only in very early sales motion. Converting these opportunities requires execution, so expected channel expansion may take longer or deliver less scale than planned.
Omada Health, Inc. News
OMDA FAQ
What was Omada Health, Inc.’s price range in the past 12 months?
Omada Health, Inc. lowest stock price was $10.28 and its highest was $26.91 in the past 12 months.
What is Omada Health, Inc.’s market cap?
Omada Health, Inc.’s market cap is $1.25B.
When is Omada Health, Inc.’s upcoming earnings report date?
Omada Health, Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 32 days.
How were Omada Health, Inc.’s earnings last quarter?
Omada Health, Inc. released its earnings results on Aug 06, 2026. The company reported $0.175 earnings per share for the quarter, beating the consensus estimate of $0.062 by $0.113.
Is Omada Health, Inc. overvalued?
According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued.
Does Omada Health, Inc. pay dividends?
Omada Health, Inc. does not currently pay dividends.
What is Omada Health, Inc.’s EPS estimate?
Omada Health, Inc.’s EPS estimate is 0.07.
How many shares outstanding does Omada Health, Inc. have?
Omada Health, Inc. has 61,216,700 shares outstanding.
What happened to Omada Health, Inc.’s price movement after its last earnings report?
Omada Health, Inc. reported an EPS of $0.175 in its last earnings report, beating expectations of $0.062. Following the earnings report the stock price went up 21.136%.
Which hedge fund is a major shareholder of Omada Health, Inc.?
Currently, no hedge funds are holding shares in OMDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Omada Health, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$28.27 (21.29% Upside)
$28.27 (21.29% Upside)
Blogger Sentiment
Bullish
OMDA Sentiment 60%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 19.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 9.1%
Last 30 Days ▲ 9.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.02%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Omada Health, Inc.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
OMDA Company Deck
OMDA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: record revenue, significant margin expansion, profitability, rapid membership growth, AI-driven efficiency gains, product launches (GLP-1 prescribing, cholesterol), and raised full-year guidance. Noted risks include seasonal moderation in H2, employer uncertainty around GLP-1 coverage, early-stage channels that require execution, and some near-term margin moderation as investments annualize. Overall the positives are broad and material and management provided clear plans to scale and convert pipeline.View all OMDA earnings summariesOMDA Stock 12 Month Forecast
Average Price Target
$28.27
▲(21.29% Upside)
Technical Analysis
Teladoc
―
American Well
―
GoodRx Holdings
―
Privia Health Group
―
Hinge Health, Inc. Class A
―
Ownership Overview
3.52% Insiders
15.16% Mutual Funds
38.67% Other Institutional Investors
34.57% Public Companies and
Individual Investors